These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 1687129)
1. Inhaled formoterol during one year in asthma: a comparison with salbutamol. Arvidsson P; Larsson S; Löfdahl CG; Melander B; Svedmyr N; Wåhlander L Eur Respir J; 1991 Nov; 4(10):1168-73. PubMed ID: 1687129 [TBL] [Abstract][Full Text] [Related]
2. A study with cumulative doses of formoterol and salbutamol in children with asthma. Foucard T; Lönnerholm G Eur Respir J; 1991 Nov; 4(10):1174-7. PubMed ID: 1687130 [TBL] [Abstract][Full Text] [Related]
3. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily]. Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083 [TBL] [Abstract][Full Text] [Related]
4. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma. Aziz I; Hall IP; McFarlane LC; Lipworth BJ J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449 [TBL] [Abstract][Full Text] [Related]
5. [The effect of a single dose of formoterol using an aerosol inhaler in asthmatic children. A randomized, controlled, double-blind study]. Lebecque P; Vliers S; De Saint-Moulin T; Godding V Rev Mal Respir; 1994; 11(1):47-50. PubMed ID: 7907426 [TBL] [Abstract][Full Text] [Related]
6. Assessment of a relative therapeutic index between inhaled formoterol and salbuterol in asthma patients. Rosenborg J; Larsson P; Rott Z; Böcskei C; Poczi M; Juhász G Eur J Clin Pharmacol; 2002 Jul; 58(4):S61-7. PubMed ID: 12214580 [TBL] [Abstract][Full Text] [Related]
7. Formoterol, a new long-acting bronchodilator for inhalation. Arvidsson P; Larsson S; Löfdahl CG; Melander B; Wåhlander L; Svedmyr N Eur Respir J; 1989 Apr; 2(4):325-30. PubMed ID: 2737271 [TBL] [Abstract][Full Text] [Related]
8. A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma. Kesten S; Chapman KR; Broder I; Cartier A; Hyland RH; Knight A; Malo JL; Mazza JA; Moote DW; Small P Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):622-5. PubMed ID: 1892303 [TBL] [Abstract][Full Text] [Related]
9. The pulmonary and extra-pulmonary effects of high-dose formoterol in COPD: a comparison with salbutamol. Goldkorn A; Diotto P; Burgess C; Weatherall M; Holt S; Beasley R; Siebers R Respirology; 2004 Mar; 9(1):102-8. PubMed ID: 14982610 [TBL] [Abstract][Full Text] [Related]
10. Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study. Aalbers R; Boorsma M; van der Woude HJ; Jonkers RE Respir Res; 2010 May; 11(1):66. PubMed ID: 20509942 [TBL] [Abstract][Full Text] [Related]
11. Bronchodilator effect of inhaled formoterol vs salbutamol over 12 hours. Maesen FP; Smeets JJ; Gubbelmans HL; Zweers PG Chest; 1990 Mar; 97(3):590-4. PubMed ID: 1968371 [TBL] [Abstract][Full Text] [Related]
12. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. Pauwels RA; Löfdahl CG; Postma DS; Tattersfield AE; O'Byrne P; Barnes PJ; Ullman A N Engl J Med; 1997 Nov; 337(20):1405-11. PubMed ID: 9358137 [TBL] [Abstract][Full Text] [Related]
13. Formoterol, a new long acting beta 2 agonist for inhalation twice daily, compared with salbutamol in the treatment of asthma. Wallin A; Melander B; Rosenhall L; Sandström T; Wåhlander L Thorax; 1990 Apr; 45(4):259-61. PubMed ID: 1972599 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the bronchodilating effects of inhaled formoterol, salmeterol and salbutamol in asthmatic patients. Grembiale RD; Pelaia G; Naty S; Vatrella A; Tranfa CM; Marsico SA Pulm Pharmacol Ther; 2002; 15(5):463-6. PubMed ID: 12406669 [TBL] [Abstract][Full Text] [Related]
15. Cross tolerance to salbutamol occurs independently of beta2 adrenoceptor genotype-16 in asthmatic patients receiving regular formoterol or salmeterol. Lee DK; Jackson CM; Bates CE; Lipworth BJ Thorax; 2004 Aug; 59(8):662-7. PubMed ID: 15282385 [TBL] [Abstract][Full Text] [Related]
16. The duration of action of inhaled formoterol dry powder. Quebe-Fehling E; Brambilla R; Bromly CL; Fishwick K; Walters EH; Hendrick DJ Br J Clin Pract; 1996 Dec; 50(8):446-9. PubMed ID: 9039716 [TBL] [Abstract][Full Text] [Related]
17. Inhaled formoterol dry powder in the treatment of patients with reversible obstructive airway disease. A 3-month, placebo-controlled comparison of the efficacy and safety of formoterol and salbutamol, followed by a 12-month trial with formoterol. Steffensen I; Faurschou P; Riska H; Rostrup J; Wegener T Allergy; 1995 Aug; 50(8):657-63. PubMed ID: 7503401 [TBL] [Abstract][Full Text] [Related]
18. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study. Busse W; Levine B; Andriano K; Lavecchia C; Yegen U Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475 [TBL] [Abstract][Full Text] [Related]
19. A study of the duration of the bronchodilator effect of 12 micrograms and 24 micrograms of inhaled formoterol and 200 micrograms inhaled salbutamol in asthma. Sykes AP; Ayres JG Respir Med; 1990 Mar; 84(2):135-8. PubMed ID: 2371435 [TBL] [Abstract][Full Text] [Related]
20. Formoterol Turbuhaler as reliever medication in patients with acute asthma. Rubinfeld AR; Scicchitano R; Hunt A; Thompson PJ; Van Nooten A; Selroos O Eur Respir J; 2006 Apr; 27(4):735-41. PubMed ID: 16455838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]